High glucose enhances CD39 expression in vascular endothelial cells

1. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol. 2012; 8: 228-36.10.1038/nrendo.2011.183Open DOISearch in Google Scholar

2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414:813-20.10.1038/414813aSearch in Google Scholar

3. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010; 107:1058-70.10.1161/CIRCRESAHA.110.223545Search in Google Scholar

4. Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013; 17:20-33.10.1016/j.cmet.2012.11.012Search in Google Scholar

5. van den Oever IA, Raterman HG, Nurmohamed MT, Simsek S. Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators Inflamm. 2010; 2010:792393.10.1155/2010/792393Search in Google Scholar

6. Schafer A, Bauersachs J. Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis. Curr Vasc Pharmacol. 2008; 6:52-60.10.2174/157016108783331295Open DOISearch in Google Scholar

7. Robson SC, S⃞vigny J, Zimmermann H. The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal. 2006; 2:409-30.10.1007/s11302-006-9003-5Open DOISearch in Google Scholar

8. Wang TF, Guidotti G. CD39 is an ecto-(Ca2+,Mg2+)- apyrase. J Biol Chem. 1996; 271:9898-901.10.1074/jbc.271.17.9898Search in Google Scholar

9. Wang TF, Guidotti G. Widespread expression of ectoapyrase (CD39) in the central nervous system. Brain Res. 1998; 790:318-22.10.1016/S0006-8993(97)01562-XSearch in Google Scholar

10. Dwyer KM, Deaglio S, Gao W, Friedman D, Strom TB, Robson SC. CD39 and control of cellular immune responses. Purinergic Signal. 2007; 3:171-80.10.1007/s11302-006-9050-y209676618404431Open DOISearch in Google Scholar

11. Atkinson B, Dwyer K, Enjyoji K, Robson SC. Ectonucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets. Blood Cells Mol Dis. 2006; 36: 217-22.10.1016/j.bcmd.2005.12.025Search in Google Scholar

12. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Alyonycheva TN, Safier LB, et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest. 1997; 99:1351-60.10.1172/JCI119294Search in Google Scholar

13. Koziak K, Sevigny J, Robson SC, Siegel JB, Kaczmarek E. Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes. Thromb Haemost. 1999; 82:1538-44.10.1055/s-0037-1614868Search in Google Scholar

14. Michno A, Bielarczyk H, Pawelczyk T, Jankowska- Kulawy A, Klimaszewska J, Szutowicz A. Alterations of adenine nucleotide metabolism and function of blood platelets in patients with diabetes. Diabetes. 2007; 56:462-7.10.2337/db06-0390Search in Google Scholar

15. Sobol AB, Watala C. The role of platelets in diabetesrelated vascular complications. Diabetes Res Clin Pract. 2000; 50:1-16.10.1016/S0168-8227(00)00160-1Open DOISearch in Google Scholar

16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65: 55-63.10.1016/0022-1759(83)90303-4Search in Google Scholar

17. Oez S, Platzer E, Welte K. A quantitative colorimetric method to evaluate the functional state of human polymorphonuclear leukocytes. Blut. 1990; 60:97-102.10.1007/BF017205152302467Search in Google Scholar

18. Ido Y, Carling D, Ruderman N. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes. 2002; 51:159-67.10.2337/diabetes.51.1.15911756336Open DOISearch in Google Scholar

19. Leal EC, Aveleira CA, Castilho AF, Serra AM, Baptista FI, Hosoya K, et al. High glucose and oxidative/nitrosative stress conditions induce apoptosis in retinal endothelial cells by a caspaseindependent pathway. Exp Eye Res. 2009; 88:983-91.10.1016/j.exer.2008.12.01019146853Search in Google Scholar

20. Altannavch TS, Roubalova K, Kucera P, Andel M. Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation. Physiol Res. 2004; 53:77-82.10.33549/physiolres.930343Search in Google Scholar

21. Yang Z, Laubach VE, French BA, Kron IL. Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion. J Thorac Cardiovasc Surg. 2009; 137:723-9.10.1016/j.jtcvs.2008.08.056268002719258097Search in Google Scholar

22. Yano M, Hasegawa G, Ishii M, Yamasaki M, Fukui M, Nakamura N, et al. Short-term exposure of high glucose concentration induces generation of reactive oxygen species in endothelial cells: implication for the oxidative stress associated with postprandial hyperglycemia. Redox Rep. 2004; 9:111-6.10.1179/13510000422500477915231066Open DOISearch in Google Scholar

23. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006 ; 295:1681-7.10.1001/jama.295.14.168116609090Search in Google Scholar

24. Favaloro EJ. Differential expression of surface antigens on activated endothelium. Immunol Cell Biol. 1993; 71:571-81.10.1038/icb.1993.638314284Search in Google Scholar

25. Kapojos JJ, van den Berg A, Borghuis T, Banas B, Huitema S, Poelstra K, et al. Enhanced ecto-apyrase activity of stimulated endothelial or mesangial cells is downregulated by glucocorticoids in vitro. Eur J Pharmacol. 2004; 501:191-8.10.1016/j.ejphar.2004.08.00815464078Search in Google Scholar

26. Wurm A, Iandiev I, Hollborn M, Wiedemann P, Reichenbach A, Zimmermann H, et al. Purinergic receptor activation inhibits osmotic glial cell swelling in the diabetic rat retina. Exp Eye Res. 2008; 87:385-93.10.1016/j.exer.2008.07.00418687327Search in Google Scholar

27. Lunkes GI, Lunkes DS, Leal D, Araujo Mdo C, Correa M, Becker L, et al. Effect of high glucose levels in human platelet NTPDase and 5?-nucleotidase activities. Diabetes Res Clin Pract. 2008; 81:351-7.10.1016/j.diabres.2008.06.00118644642Search in Google Scholar

28. Garcia-Hernandez MH, Portales-Cervantes L, Cortez- Espinosa N, Vargas-Morales JM, Fritche Salazar JF, Rivera-Lopez E, et al. Expression and function of P2X(7) receptor and CD39/Entpd1 in patients with type 2 diabetes and their association with biochemical parameters. Cell Immunol. 2011; 269:135-43. 10.1016/j.cellimm.2011.03.02221492831Search in Google Scholar